Hyperion™ International Registry Trial

计划入组 200 人 · 首次发布于 2014 年 8 月 19 日

Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma

计划入组 51 人 · 首次发布于 2020 年 5 月 26 日

Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction

计划入组 70 人 · 首次发布于 2017 年 12 月 26 日

Hypericin

C₃₀H₁₆O₈

Hypericin/Povidone

Hypericin sodium

HYPERION THERAPEUTICS, INC.

United States

HEMERION THERAPEUTICS

France

Esperion Therapeutics Inc

Costa Rica

Merck Halts Phase 3 HYPERION Trial of Winrevair Early After Positive ZENITH Results

Winrevair Demonstrates Significant Efficacy in Advanced Pulmonary Arterial Hypertension

Sotatercept Leads PAH Treatment Revolution While Combination Therapy Faces Market Hurdles